Overview

Study of Apatinib in Metastatic Esophageal Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of apatinib in Metastatic Esophageal Cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Huai'an First People's Hospital
Collaborator:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Apatinib